Stress‐ (and Diet‐) Related Regulation of Hepatic Nuclear Receptors and Its Relevance for ABC‐Transporter Functions

References

• Angulo P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 2002; 346(16)1221–1231, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Beigneux A. P., Moser A. H., Shigenaga J. K., Grunfeld C., Feingold K. R. The acute phase response is associated with retinoid X receptor repression in rodent liver. Biol. Chem. 2000; 275(21)16390–16399, [CROSSREF]
   Web of Science ®Google Scholar
• Beigneux A. P., Moser A. H., Shigenaga J. K., Grunfeld C., Feingold K. R. Reduction in cytochrome P‐450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. Biochem. Biophys. Res. Commun. 2002; 293(1)145–149, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Blanquart C., Barbier O., Fruchart J. C., Staels B., Glineur C. Peroxisome proliferator‐activated receptors: regulation of transcriptional activities and roles in inflammation. J. Steroid Biochem. Mol. Biol. 2003; 85(2–5)267–273, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Boelsterli U. A., Bedouchac M. Toxicological consequences of altered peroxisome proliferator‐activated receptor (PPARγ) expression in the liver: insights from models of obesity and type 2 diabetes. Biochem. Pharmacol. 2002; 63: 1–10, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Cabrero A., Laguna J. C., Vazquez M. Peroxisome proliferator‐activated receptors and the control of inflammation. Curr. Drug Targets Inflamm. Allergy 2002; 1(3)243–248, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Castrillo A., Joseph S. B., Vaidya S. A., Haberland M., Fogelman A. M., Cheng G., Tontonoz P. Crosstalk between LXR and toll‐like receptor signalling mediates bacterial and viral antagonism of cholesterol metabolism. Mol. Cell 2003; 12(4)805–816, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Cesari M., Penninx B. W., Newman A. B., Kritchevsky S. B., Nicklas B. J., Sutton‐Tyrrell K., Rubin S. M., Ding J., Simonsick E. M., Harris T. B., Pahor M. Inflammatory markers and onset of cardiovascular events: results from the health ABC study. Circulation 2003; 108(19)2317–2322, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Chou C. J., Haluzik M., Gregory C., Dietz K. R., Vinson C., Gavrilova O., Reitman M. L. WY14, 643, A peroxisome proliferator‐activated receptor alpha (PPARalpha) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A‐ZIP/F‐1 mice. J. Biol. Chem. 2002; 277(27)24484–24489, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Delerive P., De Bosscher K., Besnard S., Vanden Berghe W., Peters J. M., Gonzalez F. J., Fruchart J. C., Tedgui A., Haegeman G., Staels B. Peroxisome proliferator‐activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross‐talk with transcription factors NF‐kappaB and AP‐1. J. Biol. Chem. 1999; 274(45)32048–32054, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Delerive P., De Bosscher K., Vanden Berghe W., Fruchart J. C., Haegeman G., Staels B. DNA binding‐independent induction of IkappaBalpha gene transcription by PPARalpha. Mol. Endocrinol. 2002; 16(5)1029–1039, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Desreumaux P., Dubuquoy L., Nutten S. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator‐activated receptor gamma (PPARgamma) heterodimer: a basis for new therapeutic strategies. Exp. Med. 2001; 193: 827–838, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Desvergne B., Wahli W. Peroxisome proliferator‐activated receptors: nuclear control of metabolism. Endocr. Rev. 1999; 20(5)649–688, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Devchand P. R., Keller H., Peters J. M., Vazquez M., Gonzalez F. J., Wahli W. The PPARα‐leukotriene B4 pathway to inflammation control. Nature 1996; 384(6604)39–43, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Dubuquoy L., Dharancy S., Nutten S., Pettersson S., Auwerx J., Desreumaux P. Role of peroxisome proliferator‐activated receptor and retinoid X receptor heterodimer in hepatogastroenterological diseases. Lancet 2002; 360(9343)1410–1418, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Galli A., Crabb D. W., Ceni E., Salzano R., Mello T., Svegliati‐Baroni G., Ridolfi F., Trozzi L., Surrenti C., Casini A. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology 2002; 122(7)1924–1940, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gelman L., Fruchart J. C., Auwerx J. An update on the mechanisms of action of the peroxisome proliferator‐activated receptors (PPARs) and their roles in inflammation and cancer. Cell. Mol. Life Sci. 1999; 55(6–7)932–943, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Gervois P., Vu‐Dac N., Kleemann R., Kockx M., Dubois G., Laine B., Kosykh V., Fruchart J. C., Kooistra T., Staels B. Negative regulation of human fibrinogen gene expression by peroxisome proliferator‐activated receptor alpha agonists via inhibition of CCAAT box/enhancer‐binding protein beta. J. Biol. Chem. 2001; 276(36)33471–33477, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ghosh S., May M. J., Kopp E. B. NF‐κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 1998; 16: 225–260, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Handschin C., Meyer U. A. Induction of drug metabolism: the role of nuclear receptors. Pharmacol. Rev. 2003; 55(4)649–673, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hellemans K., Michalik L., Dittie A., Knorr A., Rombouts K., De Jong J., Heirman C., Quartier E., Schuit F., Wahli W., Geerts A. Peroxisome proliferator‐activated receptor‐beta signaling contributes to enhanced proliferation of hepatic stellate cells. Gastroenterology 2003; 124(1)184–201, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Heyninck K., Wullaert A., Beyaert R. Nuclear factor‐kappa B plays a central role in tumour necrosis factor‐mediated liver disease. Biochem. Pharmacol. 2003; 66(8)1409–1415, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hoekstra M., Kruijt J. K., Van Eck M., Van Berkel T. J. Specific gene expression of ATP‐binding cassette transporters and nuclear hormone receptors in rat liver parenchymal, endothelial, and Kupffer cells. J. Biol. Chem. 2003; 278(28)25448–25453, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ip E., Farrell G. C., Robertson G., Hall P., Kirsch R., Leclercq I. Central role of PPARα‐dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology 2003; 38: 123–132, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Juge‐Aubry C. E., Hammar E., Siegrist‐Kaiser C., Pernin A., Takeshita A., Chin W. W., Burger A. G., Meier C. A. Regulation of the transcriptional activity of the peroxisome proliferator‐activated receptor alpha by phosphorylation of a ligand‐independent transactivating domain. J. Biol. Chem. 1999; 274(15)10505–10510, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Karpen S. J. Nuclear receptor regulation of hepatic function. J. Hepatol. 2002; 36(6)832–850, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kersten S. Peroxisome proliferator activated receptors and obesity. Eur. J. Pharmacol. 2002; 440: 223–234, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kersten S., Seydoux J., Peters J. M., Gonzalez F. J., Desvergne B., Wahli W. Peroxisome proliferator‐activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 1999; 103(11)1489–1498, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Khovidhunkit W., Moser A. H., Shigenaga J. K., Grunfeld C., Feingold K. R. Endotoxin down‐regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR. J. Lipid Res. 2003; 44: 1728–1736, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kim M. S., Shigenaga J., Moser A., Feingold K., Grunfeld C. Repression of farnesoid X receptor during the acute phase response. J. Biol. Chem. 2003; 278(11)8988–8995, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kleemann R., Gervois P. P., Verschuren L., Staels B., Princen H. M., Kooistra T. Fibrates down‐regulate IL‐1‐stimulated C‐reactive protein gene expression in hepatocytes by reducing nuclear p50‐NF kB‐C/EBP‐complex formation. Blood 2003; 101(2)545–551, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kok T., Bloks V. W., Wolters H., Havinga R., Jansen P. L.M., Staels B., Kuipers F. Peroxisome proliferator‐activated receptor a (PPARα)‐mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice. Biochem. J. 2003; 369: 539–547, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kon K., Ikejima K., Hirose M., Yoshikawa M., Enomoto N., Kitamura T., Takei Y., Sato N. Pioglitazone prevents early‐phase hepatic fibrogenesis caused by carbon tetrachloride. Biochem. Biophys. Res. Commun. 2002; 291(1)55–61, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Laffitte B. A., Joseph S. B., Walczak R., Pei L., Wilpitz D. C., Collins J. L., Tontonoz P. Autoregulation of the human liver X receptor α promoter. Mol. Cell. Biol. 2001; 21(22)7558–7568, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lee C. H., Olson P., Evans R. M. Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator‐activated receptors. Endocrinology 2003; 144(6)2201–2207, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Li Q., Verma I. M. NF‐kappaB regulation in the immune system. Nat. Rev., Immunol. 2002; 2(10)725–734, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Madej A., Okopien B., Kowalski J., Zielinski M., Wysocki J., Szygula B. Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia Hb. Int. J. Clin. Pharmacol. Ther. 1998; 36: 345–349, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Mandard S., Müller M., Kersten S. Peroxisome proliferator‐activated receptor alpha target genes. Cell. Mol. Life Sci. 2004; 61(4)393–416, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Marcellin P., Asselah T., Boyer N. Fibrosis and disease progression in hepatitis C. Hepatology 2002; 36(5 Suppl. 1)s47–s57, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Marchesini G., Forlani G. NASH and the metabolic syndrome. Hepatology 2002; 35(2)497–499, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Mohan R., Heyman R. A. Orphan nuclear receptor modulators. Curr. Top. Med. Chem. 2003; 3(14)1637–1647, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Moshage H. Cytokines and the hepatic acute phase response. J. Pathol. 1997; 181: 257–266, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Müller M., Kersten S. Nutrigenomics: goals and strategies. Nat. Rev., Genet. 2003; 4: 315–322, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Neuschwander‐Tetri B. A., Brunt E. M., Wehmeier K. R., Oliver D., Bacon B. R. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR‐γ ligand rosiglitazone. Hepatology 2003; 38: 1008–1017, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Nuclear Receptors Committee. A unified nomenclature system for the nuclear receptor subfamily. Cell 1999; 97(2)161–163, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Okaya T., Lentsch A. B. Peroxisome proliferator‐activated receptor‐alpha regulates post‐ischemic liver injury. Am. J. Physiol. Gasterointest. Liver Physiol. 2004; 286(4)G606–G612
   PubMed Web of Science ®Google Scholar
• Pineda Torra I., Claudel T., Duval C., Kosykh V., Fruchart J. C., Staels B. Bile acids induce the expression of the human peroxisome proliferator‐activated receptor α gene via activation of the farnesoid X receptor. Mol. Endocrinol. 2003; 17(2)259–272, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Pineda Torra I., Jamshidi Y., Flavell D. M., Fruchart J. C., Staels B. Characterization of the human PPARα promoter: identification of a functional nuclear receptor response element. Mol. Endocrinol. 2002; 16(5)1013–1028, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Roberts R. A., Chevalier S., Hasmall S. C., James N. H., Cosulich S. C., Macdonald N. PPAR alpha and the regulation of cell division and apoptosis. Toxicology 2002; 181–182: 167–170, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Saxena R., Zucker S. D., Crawford J. M. Anatomy and physiology of the liver. Hepatology, A Textbook of Liver Disease4th ed., D. Zakim, T. D. Boyer. Saunders, Elsevier Science. 2003; Vol. 1: 3–30
   Google Scholar
• Schoonjans K., Staels B., Auwerx J. Role of the peroxisome proliferator‐activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 1996; 37: 907–925, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Scotto K. W. Transcriptional regulation of ABC drug transporters. Oncogene 2003; 22(47)7496–7511, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Sekiya M., Yahagi N., Matsuzaka T., Najima Y., Nakakuki M., Nagai R., Ishibashi S., Osuga J., Yamada N., Shimano H. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP‐1 suppression. Hepatology 2003; 38(6)1529–1539, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Shalev A., Siegrist‐Kaiser C. A., Yen P. M., Wahli W., Burger A. G., Chin W. W., Meier C. A. The peroxisome proliferator‐activated receptor alpha is a phosphoprotein: regulation by insulin. Endocrinology 1996; 137(10)4499–4502, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Stravitz R. T., Sanyal A. J. Drug‐induced steatohepatitis. Clin. Liver Dis. 2003; 7(2)435–451, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Tanaka T., Itoh H., Doi K., Fukunaga Y., Hosoda K., Shintani M. Down regulation of peroxisome proliferator‐activated receptor g expression by inflammatory cytokines and its reversal by thiazolidinediones. Diabetologia 1999; 42(6)702–710, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Tugwood J. D., Aldridge T. C., Lambe K. G., Macdonald N., Woodyatt N. J. Peroxisome proliferator‐activated receptors: structures and function. Ann. N.Y. Acad. Sci. 1996; 804: 252–265, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Uchimura K., Nakamuta M., Enjoji M., Irie T., Sugimoto R., Muta T., Iwamoto H., Nawata H. Activation of retinoic X receptor and peroxisome proliferator‐activated receptor‐gamma inhibits nitric oxide and tumor necrosis factor‐alpha production in rat Kupffer cells. Hepatology 2001; 33(1)91–99, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Viollet B., Kahn A., Raymondjean M. Protein kinase A‐dependent phosphorylation modulates DNA‐binding activity of hepatocyte nuclear factor 4. Mol. Cell. Biol. 1997; 17(8)4208–4219, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Wang Y. X., Lee C. H., Tiep S., Yu R. T., Ham J., Kang H., Evans R. M. Peroxisome‐proliferator‐activated receptor delta activates fat metabolism to prevent obesity. Cell 2003; 113: 159–170, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Watt A. J., Garrison W. D., Duncan S. A. HNF4: a central regulator of hepatocyte differentiation and function. Hepatology 2003; 37(6)1249–1253, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Xu J., Fu Y., Chen A. Activation of peroxisome proliferator‐activated receptor‐γ contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am. J. Physiol. Gasterointest. Liver Physiol. 2003; 285: G20–G30
   PubMed Web of Science ®Google Scholar
• Yu S., Matsusue K., Kashireddy P., Cao W. Q., Yeldandi V., Yeldandi A. J., Rao M., Gonzalez F. J., Reddy J. K. Adipocyte‐specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator‐activated receptor γ1 (PPARγ 1) overexpression. J. Biol. Chem. 2003; 278(1)498–505, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar